WASHINGTON--(BUSINESS WIRE)-- The U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) today awarded a $153 million contract to Cellerant ...

Barda, an award-winning Argentinian steakhouse in Detroit’s Core City neighborhood, announced its new, multi-course “Steakhouse Sundays” starting Dec. 15.

BARDA has set separate response dates for each technology area, the earliest on Sept. 15 for diagnostics and medical devices and the latest on Jan. 12, 2024, for digital health and special ...

The ClinicalTrials.gov identifier is NCT04470427. ... (DARPA), an agency of the U.S. Department of Defense, and the Biomedical Advanced Research and Development Authority ...

The Biomedical Advanced Research and Development Authority (https://medicalcountermeasures.gov/barda/) is an office of the United States Department of Health and Human Services.

How the US Government through BARDA's DRIVe Initiative is looking to fight global healthcare threats like sepsis, antibiotic resistance and Ebola.

Every day the U.S. faces threats like Zika, Ebola and Pandemic Flu. The CEO of United Therapeutics, Dr. Martine Rothblatt, explains and advocates for the government agency BARDA in their constant ...

The ClinicalTrials.gov listing for mRNA-1273 describes the shot as a LNP ... Moderna’s shares were up 7% premarket Monday morning on its BARDA boost. coronavirus COVID-19 funding pandemic ...

Millions earmarked for public health emergencies were used to pay for unrelated projects, inspector general says. Staff called the agency the ‘bank of BARDA’ and said research and development ...

BARDA also supports development of medicines to treat radiation-combined injury, ... Proposals are accepted through the Broad Agency Announcement BARDA-CBRN-BAA-11-100-SOL-00009 at www.fbo.gov.

“You can think of BARDA almost like a venture capital firm buried in the U.S. government,” he says. To find an Ebola treatment, BARDA is investing in the most promising drugs and vaccines.

The U.S. Biomedical Advanced Research and Development Authority, or BARDA, is working with Johnson & Johnson to find and produce a vaccine in a gargantuan deal for the new agency.